A Grave Outcome of Posterior Reversible Encephalopathy Syndrome in a Patient Receiving Avastin (Bevacizumab) for Metastatic High-Grade Serous Ovarian Cancer

A Grave Outcome of Posterior Reversible Encephalopathy Syndrome in a Patient Receiving Avastin (Bevacizumab) for Metastatic High-Grade Serous Ovarian Cancer

A 45-year-old female developed neurological symptoms and elevated diastolic blood pressure while on bevacizumab (Avastin) and gemcitabine for recurrent carboplatin-resistant high-grade serous ovarian cancer. A brain MRI diagnosed our patient with posterior reversible encephalopathy syndrome. We are...

Full description

Bibliographic Details
Main Authors: Hind H. Elmalik, Shereen ElAzzazy, Khaled S. Salem, Salha Bujassoum
Format: Article
Language:English
Published: Karger Publishers 2015-07-01
Series:Case Reports in Oncology
Subjects:
Posterior reversible encephalopathy syndrome
Bevacizumab
Online Access:http://www.karger.com/Article/FullText/435805

Internet

http://www.karger.com/Article/FullText/435805

Similar Items